e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Protara Therapeutics, Inc. - Common Stock (NQ:TARA)

5.660 -0.240 (-4.07%)

Streaming Delayed Price Updated: 1:48 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Protara Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Protara Therapeutics Shares Interim Data From Bladder Cancer Study, Raises $45M Via Equity ↗

April 05, 2024

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, and future plans. Stay updated on Protara Therapeutics' advancements in cancer...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 05, 2024

Via Benzinga

3 Stocks That Could Help You Retire on a Private Island ↗

March 23, 2024

If you want extreme gains, you’ve got to take extreme risks. These stocks to help you retire on a private island might help.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 11, 2023

Via Benzinga

Recap: Protara Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

Protara Therapeutics Releases Early Cut Data From Investigational Cell-Based Therapy For Bladder Cancer ↗

April 28, 2023

Via Benzinga

Protara Therapeutics Shares Retrospective Analysis Of OK-432 In Rare Lymphatic Malformations ↗

May 12, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 10, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 15, 2023

Friday's session saw 169 companies set new 52-week lows.

Via Benzinga

Protara Therapeutics: Q3 Earnings Insights ↗

November 03, 2022

Protara Therapeutics (NASDAQ:TARA) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗

October 05, 2022

Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Executives Buy Around $35M Of 4 Penny Stocks: Nextdoor, GreenLight Biosciences And More ↗

August 16, 2022

The Dow Jones jumped by around 150 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 08, 2023

Friday's session saw 225 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 03, 2022

Tuesday's session saw 211 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

November 09, 2022

On Wednesday, 283 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 29, 2022

On Friday, 213 companies hit new 52-week lows.

Via Benzinga

Recap: Protara Therapeutics Q4 Earnings ↗

March 09, 2022

Protara Therapeutics (NASDAQ:TARA) reported its Q4 earnings results on Wednesday, March 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement....

Via Benzinga

11 Things to Know About Protara Therapeutics as TARA Stock Soars on Big FDA News ↗

October 12, 2021

Protara Therapeutics (TARA) stock is heading higher on Tuesday following some major news from the FDA concerning clinical trials.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

Why Protara Therapeutics Stock Is Rising Today ↗

October 12, 2021

Protara Therapeutics Inc (NASDAQ: TARA) is trading higher Tuesday after the company announced FDA clearance of the Investigational New Drug application for TARA-002 for the...

Via Benzinga

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 12, 2021

Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 23, 2021

Gainers TransCode Therapeutics (NASDAQ:RNAZ) stock rose 94.3% to $5.09 during Thursday's regular session. TransCode Therapeutics's stock is trading at a volume of...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

60 Biggest Movers From Yesterday ↗

August 25, 2021

Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy